{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T14:18:54Z","timestamp":1792592334997,"version":"4.5.0"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T00:00:00Z","timestamp":1781568000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T00:00:00Z","timestamp":1781568000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100018950","name":"Centre Hospitalier Universitaire de Rennes","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100018950","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Virchows Arch"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Autoimmune Hepatitis (AIH) is a liver disease with a wide clinical spectrum, driven by an abnormal immune response against the liver parenchyma. Challenges persist especially in terms of accurate diagnosis of acute onsets and differential diagnosis, outlined by the European Association for the Study of Liver guidelines. Our training cohort comprised 170 untreated AIH and 232 control cases with a variety of differential diagnosis. Ground Truth was the integrative diagnosis of the clinical, histological, biological and treatment response data. We trained a multiple-instance deep-learning model (DLM) from Whole Slide Images alone for the initial diagnosis of AIH. The model was then tested on an external dataset of 61 AIH and 124 controls. Prospective real-life testing of the model was conducted between January and June 2025. Our DLM \u201cArtificial Intelligence On Liver Immunity (AIOLI)\u201d achieved an AUC of 0,92\u2009\u00b1\u20090,02 on the training dataset and an AUC of 0,74 on the external dataset; in detail, it achieved an AUC of 0,89 for the differential diagnosis of AIH vs. acute alcoholic hepatitis, 0,98 vs. MASH, 0,42 vs. Hepatitis B Virus and 0,76 vs. drug-induced liver injuries. Retrieval of the five most predictive tiles allowed to identify patterns used by the model for prediction and provided interpretability. In the prospective setting, AIOLI achieved a Sensibility of 0.86, a Specificity of 0.76, a F1-score of 0.69 and an AUC of 0.73. AIOLI is an interpretable DLM able to segregate AIH from a variety of control cases with performances comparable to those of an expert liver pathologist, setting a benchmark for future research. We plan to enhance our performances by enriching our dataset, and to validate this approach with a multicentric deployment.<\/jats:p>","DOI":"10.1007\/s00428-026-04621-z","type":"journal-article","created":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T06:58:23Z","timestamp":1781593103000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["High performance deep-learning model for the diagnosis of auto-immune hepatitis based on histological whole slide images"],"prefix":"10.1007","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6179-3396","authenticated-orcid":false,"given":"Pierre","family":"Allaume","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"No\u00e9mie","family":"Rabilloud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Sessa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julien","family":"Cald\u00e9raro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morgane","family":"Pierre-Jean","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thierry","family":"P\u00e9cot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Lor\u00e9al","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sol\u00e8ne-Florence","family":"Kammerer-Jacquet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edouard","family":"Bardou-Jacquet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno","family":"Turlin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,16]]},"reference":[{"issue":"5","key":"4621_CR1","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1136\/gut.42.5.599","volume":"42","author":"IG McFarlane","year":"1998","unstructured":"McFarlane IG (1998) The relationship between autoimmune markers and different clinical syndromes in autoimmune hepatitis. Gut 42(5):599\u2013602","journal-title":"Gut"},{"issue":"1","key":"4621_CR2","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.jhep.2010.12.012","volume":"55","author":"AW Lohse","year":"2011","unstructured":"Lohse AW, Mieli-Vergani G (2011) Autoimmune hepatitis. J Hepatol 55(1):171\u2013182","journal-title":"J Hepatol"},{"issue":"10","key":"4621_CR3","doi-asserted-by":"publisher","first-page":"1676","DOI":"10.1111\/jgh.14746","volume":"34","author":"T Lv","year":"2019","unstructured":"Lv T, Li M, Zeng N, Zhang J, Li S, Chen S et al (2019) Systematic review and meta-analysis on the incidence and prevalence of autoimmune hepatitis in Asian, European, and American population. J Gastroenterol Hepatol 34(10):1676\u20131684","journal-title":"J Gastroenterol Hepatol"},{"issue":"1","key":"4621_CR4","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.jhep.2023.09.010","volume":"80","author":"F Colapietro","year":"2024","unstructured":"Colapietro F, Maisonneuve P, Lytvyak E, Beuers U, Verdonk RC, van der Meer AJ et al (2024) Incidence and predictors of hepatocellular carcinoma in patients with autoimmune hepatitis. J Hepatol 80(1):53\u201361","journal-title":"J Hepatol"},{"issue":"2","key":"4621_CR5","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1016\/j.jhep.2025.03.017","volume":"83","author":"European Association for the Study of the Liver","year":"2025","unstructured":"European Association for the Study of the Liver (2025) EASL Clinical Practice Guidelines on the management of autoimmune hepatitis. J Hepatol 83(2):453\u2013501","journal-title":"J Hepatol"},{"issue":"2","key":"4621_CR6","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1002\/hep.31065","volume":"72","author":"CL Mack","year":"2020","unstructured":"Mack CL, Adams D, Assis DN, Kerkar N, Manns MP, Mayo MJ et al (2020) Diagnosis and Management of Autoimmune Hepatitis in Adults and Children: 2019 Practice Guidance and Guidelines From the American Association for the Study of Liver Diseases. Hepatology 72(2):671\u2013722","journal-title":"Hepatology"},{"issue":"4","key":"4621_CR7","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1002\/hep.1840180435","volume":"18","author":"PJ Johnson","year":"1993","unstructured":"Johnson PJ, McFarlane IG (1993) Meeting report: International Autoimmune Hepatitis Group. Hepatology 18(4):998\u20131005","journal-title":"Hepatology"},{"issue":"5","key":"4621_CR8","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1016\/S0168-8278(99)80297-9","volume":"31","author":"F Alvarez","year":"1999","unstructured":"Alvarez F, Berg PA, Bianchi FB, Bianchi L, Burroughs AK, Cancado EL et al (1999) International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis. J Hepatol 31(5):929\u2013938","journal-title":"J Hepatol"},{"issue":"1","key":"4621_CR9","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1002\/hep.22322","volume":"48","author":"EM Hennes","year":"2008","unstructured":"Hennes EM, Zeniya M, Czaja AJ, Par\u00e9s A, Dalekos GN, Krawitt EL et al (2008) Simplified criteria for the diagnosis of autoimmune hepatitis. Hepatology 48(1):169\u2013176","journal-title":"Hepatology"},{"issue":"2","key":"4621_CR10","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1002\/hep.23042","volume":"50","author":"AD Yeoman","year":"2009","unstructured":"Yeoman AD, Westbrook RH, Al-Chalabi T, Carey I, Heaton ND, Portmann BC et al (2009) Diagnostic value and utility of the simplified International Autoimmune Hepatitis Group (IAIHG) criteria in acute and chronic liver disease. Hepatology 50(2):538\u2013545","journal-title":"Hepatology"},{"issue":"3","key":"4621_CR11","first-page":"487","volume":"84","author":"O Ducazu","year":"2021","unstructured":"Ducazu O, Degroote H, Geerts A, Hoorens A, Schouten J, Van Vlierberghe H et al (2021) Diagnostic and prognostic scoring systems for autoimmune hepatitis: a review. Acta Gastroenterol Belg 84(3):487\u2013495","journal-title":"Acta Gastroenterol Belg"},{"issue":"5","key":"4621_CR12","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.1111\/liv.15217","volume":"42","author":"AW Lohse","year":"2022","unstructured":"Lohse AW, Sebode M, Bhathal PS, Clouston AD, Dienes HP, Jain D et al (2022) Consensus recommendations for histological criteria of autoimmune hepatitis from the International AIH Pathology Group: Results of a workshop on AIH histology hosted by the European Reference Network on Hepatological Diseases and the European Society of Pathology. Liver Int 42(5):1058\u20131069","journal-title":"Liver Int"},{"key":"4621_CR13","doi-asserted-by":"publisher","first-page":"20","DOI":"10.21037\/tgh.2020.04.01","volume":"6","author":"D Jain","year":"2021","unstructured":"Jain D, Torres R, Celli R, Koelmel J, Charkoftaki G, Vasiliou V (2021) Evolution of the liver biopsy and its future. Transl Gastroenterol Hepatol 6:20","journal-title":"Transl Gastroenterol Hepatol"},{"issue":"4","key":"4621_CR14","doi-asserted-by":"publisher","first-page":"388","DOI":"10.3390\/diagnostics14040388","volume":"14","author":"F Grignaffini","year":"2024","unstructured":"Grignaffini F, Barbuto F, Troiano M, Piazzo L, Simeoni P, Mangini F et al (2024) The Use of Artificial Intelligence in the Liver Histopathology Field: A Systematic Review. Diagnostics (Basel) 14(4):388","journal-title":"Diagnostics (Basel)"},{"issue":"10","key":"4621_CR15","doi-asserted-by":"publisher","first-page":"1799","DOI":"10.3390\/diagnostics13101799","volume":"13","author":"P Allaume","year":"2023","unstructured":"Allaume P, Rabilloud N, Turlin B, Bardou-Jacquet E, Lor\u00e9al O, Calderaro J et al (2023) Artificial Intelligence-Based Opportunities in Liver Pathology-A Systematic Review. Diagnostics (Basel) 13(10):1799","journal-title":"Diagnostics (Basel)"},{"key":"4621_CR16","unstructured":"The Cancer Genome Atlas Program (TCGA) - NCI [Internet] (2022) [cited 2025 Feb 24]. Available from: https:\/\/www.cancer.gov\/ccg\/research\/genome-sequencing\/tcga"},{"issue":"11","key":"4621_CR17","doi-asserted-by":"publisher","first-page":"e012799","DOI":"10.1136\/bmjopen-2016-012799","volume":"6","author":"JF Cohen","year":"2016","unstructured":"Cohen JF, Korevaar DA, Altman DG, Bruns DE, Gatsonis CA, Hooft L et al (2016) STARD 2015 guidelines for reporting diagnostic accuracy studies: explanation and elaboration. BMJ Open 6(11):e012799","journal-title":"BMJ Open"},{"key":"4621_CR18","doi-asserted-by":"publisher","first-page":"e070201","DOI":"10.1136\/bmj-2022-070201","volume":"380","author":"L Muratori","year":"2023","unstructured":"Muratori L, Lohse AW, Lenzi M (2023) Diagnosis and management of autoimmune hepatitis. BMJ 380:e070201","journal-title":"BMJ"},{"key":"4621_CR19","unstructured":"R\u00e9seau Maladies inflammatoires voies biliaires et H\u00e9patites Auto-Immunes [Internet] Filfoie: tout savoir sur les maladies rares du foie, recherche, enseignement. [cited 2025 Feb 24]. Available from: https:\/\/www.filfoie.com\/ou-consulter\/reseau-maladies-inflammatoires-voies-biliaires-hepatites-auto-immunes\/"},{"key":"4621_CR20","unstructured":"Le mode autonome avec l\u2019application BaMaRa | Banque Nationale de Donn\u00e9es Maladies Rares [Internet]. [cited 2025 Feb 24]. Available from: https:\/\/www.bndmr.fr\/participer\/mode-autonome\/"},{"issue":"6","key":"4621_CR21","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1016\/0168-8278(95)80226-6","volume":"22","author":"K Ishak","year":"1995","unstructured":"Ishak K, Baptista A, Bianchi L, Callea F, De Groote J, Gudat F et al (1995) Histological grading and staging of chronic hepatitis. J Hepatol 22(6):696\u2013699","journal-title":"J Hepatol"},{"issue":"9055","key":"4621_CR22","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1016\/S0140-6736(96)07642-8","volume":"349","author":"T Poynard","year":"1997","unstructured":"Poynard T, Bedossa P, Opolon P (1997) Natural history of liver fibrosis progression in patients with chronic hepatitis C. The OBSVIRC, METAVIR, CLINIVIR, and DOSVIRC groups. Lancet 349(9055):825\u2013832","journal-title":"Lancet"},{"key":"4621_CR23","unstructured":"QuPath [Internet] [cited 2025 Feb 25]. Available from: https:\/\/qupath.github.io\/"},{"key":"4621_CR24","doi-asserted-by":"crossref","unstructured":"Deng J, Dong W, Socher R, Li L-J, Li K, Fei-Fei L (2009) ImageNet: A large-scale hierarchical image database, 2009 IEEE Conference on Computer Vision and Pattern Recognition, Miami, FL, USA, pp. 248\u2013255","DOI":"10.1109\/CVPR.2009.5206848"},{"key":"4621_CR25","doi-asserted-by":"publisher","unstructured":"Filiot A, Ghermi R, Olivier A, Jacob P, Fidon L, Kain AM et al Scaling self-supervised learning for histopathology with masked image modeling [Internet]. medRxiv; 2023 [cited 2025 Feb 24]. p. 2023.07.21.23292757. Available from: https:\/\/www.medrxiv.org\/content\/https:\/\/doi.org\/10.1101\/2023.07.21.23292757v1","DOI":"10.1101\/2023.07.21.23292757v1"},{"key":"#cr-split#-4621_CR26.1","unstructured":"Courtiol P, Tramel EW, Sanselme M, Wainrib G, Classification (2020) and disease localization in histopathology using only global labels: a weakly-supervised approach [Internet]. arXiv"},{"key":"#cr-split#-4621_CR26.2","unstructured":"[cited 2025 Feb 26]. Available from: http:\/\/arxiv.org\/abs\/1802.02212"},{"key":"4621_CR27","unstructured":"Saxena R (2018) Practical hepatic pathology: a diagnostic approach. Second edition. Philadelphia, PA: Elsevier; (Pattern recognition series)"},{"issue":"5","key":"4621_CR28","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1111\/apt.15111","volume":"49","author":"JK Dyson","year":"2019","unstructured":"Dyson JK, De Martin E, Dalekos GN, Drenth JPH, Herkel J, Hubscher SG et al (2019) Review article: unanswered clinical and research questions in autoimmune hepatitis-conclusions of the International Autoimmune Hepatitis Group Research Workshop. Aliment Pharmacol Ther 49(5):528\u2013536","journal-title":"Aliment Pharmacol Ther"},{"issue":"7","key":"4621_CR29","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1111\/liv.15573","volume":"43","author":"RJALM Snijders","year":"2023","unstructured":"Snijders RJALM, Assis DN, Oo YH, Sebode M, Taubert R, Willemse J et al (2023) Research gaps and opportunities in autoimmune hepatitis-Results of the international autoimmune hepatitis group research workshop 2022. Liver Int 43(7):1375\u20131384","journal-title":"Liver Int"},{"issue":"2","key":"4621_CR30","doi-asserted-by":"publisher","first-page":"101265","DOI":"10.1016\/j.jhepr.2024.101265","volume":"7","author":"B Engel","year":"2024","unstructured":"Engel B, Assis DN, Bhat M, Clusmann J, Drenth JPH, Gerussi A et al (2024) Quo vadis autoimmune hepatitis? - Summary of the 5th international autoimmune hepatitis group research workshop 2024. JHEP Rep 7(2):101265","journal-title":"JHEP Rep"},{"key":"4621_CR31","doi-asserted-by":"publisher","first-page":"102280","DOI":"10.1016\/j.eclinm.2023.102280","volume":"65","author":"JW Hahn","year":"2023","unstructured":"Hahn JW, Yang HR, Moon JS, Chang JY, Lee K, Kim GA et al (2023) Global incidence and prevalence of autoimmune hepatitis, 1970\u20132022: a systematic review and meta-analysis. eClinicalMedicine 65:102280","journal-title":"eClinicalMedicine"},{"issue":"5","key":"4621_CR32","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1016\/j.jhep.2023.01.013","volume":"78","author":"G Maggiore","year":"2023","unstructured":"Maggiore G, Bernard O, Mosca A, Ballot E, Johanet C, Jacquemin E (2023) Long-term outcomes of patients with type 1 or 2 autoimmune hepatitis presenting in childhood. J Hepatol 78(5):979\u2013988","journal-title":"J Hepatol"},{"issue":"9","key":"4621_CR33","doi-asserted-by":"publisher","first-page":"2282","DOI":"10.1111\/liv.15971","volume":"44","author":"L Wang","year":"2024","unstructured":"Wang L, Du ZX, Liu HL, Zhang Y, Wang SS, Hu YF et al (2024) IAIH-PG consensus for histological criteria of AIH: Multicentre validation with focus on chronic liver diseases in China. Liver Int 44(9):2282\u20132292","journal-title":"Liver Int"},{"issue":"3","key":"4621_CR34","doi-asserted-by":"publisher","first-page":"100","DOI":"10.14744\/hf.2023.2023.0061","volume":"5","author":"K Moral","year":"2024","unstructured":"Moral K, Simsek B, Tomar VB, Albayrak C, Ergin M, Kilic G et al (2024) Comparison of the recommendation of international autoimmune hepatitis pathology group 2022 and the simplified criteria for autoimmune hepatitis 2008: A preliminary study. Hepatol Forum 5(3):100\u2013105","journal-title":"Hepatol Forum"},{"issue":"11","key":"4621_CR35","doi-asserted-by":"publisher","first-page":"2583","DOI":"10.1111\/liv.15394","volume":"42","author":"F Colapietro","year":"2022","unstructured":"Colapietro F, Masetti C, Pugliese N, Lleo A (2022) Recommendations for histological criteria of autoimmune hepatitis from the international AIH pathology: Validation on a monocentric cohort. Liver Int 42(11):2583\u20132584","journal-title":"Liver Int"},{"issue":"1","key":"4621_CR36","doi-asserted-by":"publisher","first-page":"37","DOI":"10.3350\/cmh.2023.0325","volume":"30","author":"S Ahn","year":"2024","unstructured":"Ahn S, Jeong SH, Cho EJ, Lee K, Kim G, Kim H (2024) Comparison of four histological scoring systems for autoimmune hepatitis to improve diagnostic sensitivity. Clin Mol Hepatol 30(1):37\u201348","journal-title":"Clin Mol Hepatol"},{"issue":"6","key":"4621_CR37","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1007\/s00428-024-03841-5","volume":"485","author":"C Ercan","year":"2024","unstructured":"Ercan C, Kordy K, Knuuttila A, Zhou X, Kumar D, Koponen V et al (2024) A deep-learning-based model for assessment of autoimmune hepatitis from histology: AI(H). Virchows Arch 485(6):1095\u20131105","journal-title":"Virchows Arch"},{"issue":"2","key":"4621_CR38","doi-asserted-by":"publisher","first-page":"101198","DOI":"10.1016\/j.jhepr.2024.101198","volume":"7","author":"A Gerussi","year":"2024","unstructured":"Gerussi A, Saldanha OL, Cazzaniga G, Verda D, Carrero ZI, Engel B et al (2024) Deep learning helps discriminate between autoimmune hepatitis and primary biliary cholangitis. JHEP Rep 7(2):101198","journal-title":"JHEP Rep"},{"issue":"6","key":"4621_CR39","doi-asserted-by":"publisher","first-page":"100149","DOI":"10.1016\/j.jhepr.2020.100149","volume":"2","author":"MN Rahim","year":"2020","unstructured":"Rahim MN, Miquel R, Heneghan MA (2020) Approach to the patient with acute severe autoimmune hepatitis. JHEP Rep 2(6):100149","journal-title":"JHEP Rep"},{"issue":"1","key":"4621_CR40","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1089\/adt.2019.919","volume":"18","author":"M Puri","year":"2020","unstructured":"Puri M (2020) Automated Machine Learning Diagnostic Support System as a Computational Biomarker for Detecting Drug-Induced Liver Injury Patterns in Whole Slide Liver Pathology Images. Assay Drug Dev Technol 18(1):1\u201310","journal-title":"Assay Drug Dev Technol"},{"issue":"2","key":"4621_CR41","doi-asserted-by":"publisher","first-page":"e16239","DOI":"10.1111\/liv.16239","volume":"45","author":"Y Wang","year":"2025","unstructured":"Wang Y, Lin X, Sun Y, Liu J, Li J, Tian Q et al (2025) Development and Validation of a Novel Model to Discriminate Idiosyncratic Drug-Induced Liver Injury and Autoimmune Hepatitis. Liver Int 45(2):e16239","journal-title":"Liver Int"},{"issue":"3","key":"4621_CR42","doi-asserted-by":"publisher","first-page":"337","DOI":"10.2169\/internalmedicine.3112-23","volume":"64","author":"A Takahashi","year":"2025","unstructured":"Takahashi A, Ohira H, Abe K, Zeniya M, Abe M, Arinaga-Hino T et al (2025) Autoimmune Hepatitis with Metabolic Dysfunction-associated Fatty Liver Disease. Intern Med 64(3):337\u2013342","journal-title":"Intern Med"},{"issue":"11","key":"4621_CR43","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1136\/jclinpath-2016-204271","volume":"70","author":"H Nguyen Canh","year":"2017","unstructured":"Nguyen Canh H, Harada K, Ouchi H, Sato Y, Tsuneyama K, Kage M et al (2017) Acute presentation of autoimmune hepatitis: a multicentre study with detailed histological evaluation in a large cohort of patients. J Clin Pathol 70(11):961\u2013969","journal-title":"J Clin Pathol"}],"container-title":["Virchows Archiv"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00428-026-04621-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00428-026-04621-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00428-026-04621-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T06:58:32Z","timestamp":1781593112000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00428-026-04621-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,16]]},"references-count":44,"alternative-id":["4621"],"URL":"https:\/\/doi.org\/10.1007\/s00428-026-04621-z","relation":{},"ISSN":["0945-6317","1432-2307"],"issn-type":[{"value":"0945-6317","type":"print"},{"value":"1432-2307","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,16]]},"assertion":[{"value":"26 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 May 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 June 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 June 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"None.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This study was conducted in appliance of the local guidelines (Reference Methodology MR-04) and approved by the institutional review board \u201cDirection for Research and Innovation of the Rennes University Hospital\u201d (registration number D-2932), and informed consent was obtained for all included patients. This study was performed in accordance with the Declaration of Helsinki.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}}]}}